Similar articles for PMID: 34281851

Year	Number of Results
1977	1
1985	1
1991	1
1992	3
1994	1
1995	4
1996	6
1997	6
1998	1
1999	4
2000	5
2001	7
2002	2
2003	4
2004	2
2005	2
2006	1
2007	3
2008	6
2009	3
2010	6
2011	2
2012	2
2013	1
2014	4
2015	1
2016	7
2017	3
2018	5
2019	2
2021	1
2024	0

1

Expression of Surface-associated 82 kDa proMMP-9 in Lymphatic Leukemia Blast Cells Differentially Correlates With Prognosis.

Schmohl J, Moebius S, Guenther T, Pepeldjyika E, Seidel CL, Sutanto W, Schuster F, Kraemer D, Salih H, Hartmann A, Tischer J, Ries C, Schmetzer H. Schmohl J, et al. Anticancer Res. 2021 Aug;41(8):3891-3898. doi: 10.21873/anticanres.15184. Anticancer Res. 2021. PMID: 34281851

2

Expression of surface-associated 82kDa-proMMP-9 in primary acute leukemia blast cells inversely correlates with patients' risk.

Schmohl J, Santovito D, Guenther T, Sutanto W, Kroell T, Salih H, Pitsch T, Egea V, Weber C, Schmetzer H, Ries C. Schmohl J, et al. Exp Hematol. 2016 May;44(5):358-362.e5. doi: 10.1016/j.exphem.2016.01.007. Epub 2016 Feb 2. Exp Hematol. 2016. PMID: 26845021

3

Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.

Bailón E, Ugarte-Berzal E, Amigo-Jiménez I, Van den Steen P, Opdenakker G, García-Marco JA, García-Pardo A. Bailón E, et al. J Leukoc Biol. 2014 Aug;96(2):185-99. doi: 10.1189/jlb.3HI0913-521R. J Leukoc Biol. 2014. PMID: 25080557

4

A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.

Ugarte-Berzal E, Bailón E, Amigo-Jiménez I, Vituri CL, del Cerro MH, Terol MJ, Albar JP, Rivas G, García-Marco JA, García-Pardo A. Ugarte-Berzal E, et al. J Biol Chem. 2012 Aug 10;287(33):27601-13. doi: 10.1074/jbc.M112.354670. Epub 2012 Jun 22. J Biol Chem. 2012. PMID: 22730324 Free PMC article. Clinical Trial.

5

Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.

Redondo-Muñoz J, Ugarte-Berzal E, García-Marco JA, del Cerro MH, Van den Steen PE, Opdenakker G, Terol MJ, García-Pardo A. Redondo-Muñoz J, et al. Blood. 2008 Jul 1;112(1):169-78. doi: 10.1182/blood-2007-08-109249. Epub 2008 Mar 7. Blood. 2008. PMID: 18326820 Free article.

6

Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.

Boeck CL, Amberger DC, Doraneh-Gard F, Sutanto W, Guenther T, Schmohl J, Schuster F, Salih H, Babor F, Borkhardt A, Schmetzer H. Boeck CL, et al. J Immunother. 2017 Jul/Aug;40(6):224-248. doi: 10.1097/CJI.0000000000000171. J Immunother. 2017. PMID: 28557814

7

Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.

Grywalska E, Bartkowiak-Emeryk M, Pasiarski M, Olszewska-Bożek K, Mielnik M, Podgajna M, Pieczykolan M, Hymos A, Fitas E, Surdacka A, Góźdź S, Roliński J. Grywalska E, et al. Adv Clin Exp Med. 2018 Jul;27(7):987-999. doi: 10.17219/acem/74437. Adv Clin Exp Med. 2018. PMID: 29893517 Free article.

8

Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.

Ries C, Pitsch T, Mentele R, Zahler S, Egea V, Nagase H, Jochum M. Ries C, et al. Biochem J. 2007 Aug 1;405(3):547-58. doi: 10.1042/BJ20070191. Biochem J. 2007. PMID: 17489740 Free PMC article.

9

The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.

Bühring HJ, Sures I, Jallal B, Weiss FU, Busch FW, Ludwig WD, Handgretinger R, Waller HD, Ullrich A. Bühring HJ, et al. Blood. 1995 Sep 1;86(5):1916-23. Blood. 1995. PMID: 7544646 Free article.

10

Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.

Bailón E, Ugarte-Berzal E, Amigo-Jiménez I, Van den Steen P, Opdenakker G, García-Marco JA, García-Pardo A. Bailón E, et al. J Leukoc Biol. 2014 Mar 11. doi: 10.1189/jlb.0913521. Online ahead of print. J Leukoc Biol. 2014. PMID: 24620030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year